Call for Abstract
Scientific Program
37th World Cancer Conference, will be organized around the theme “Innovations and Novel Approaches in Diagnosis and Treatment of different Cancers”
World Cancer 2019 is comprised of 24 tracks and 111 sessions designed to offer comprehensive sessions that address current issues in World Cancer 2019.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
- Track 1-1Avoiding Risk Factors
- Track 1-2Changing Lifestyle Choices
- Track 1-3Chemo preventive Measures
- Track 1-4Early Detection Research
- Track 1-5Immunoprevention
- Track 1-6Oncogenesis
- Track 1-7Preclinical & Clinical Research
- Track 3-1Cancer Genomics & Biologic Factors
- Track 3-2Identifying Risk Factors
- Track 3-3New Genotyping Technologies
- Track 3-4Physiology & Cancer History
- Track 3-5Targeted Agents & Conventional Treatment
- Track 4-1Breast Cancer, Gastrointestinal Cancer, Gynaecologic Cancers -Cervical Cancer, Uterus Cancer, Ovarian Cancer, Vulvar Cancer, Brain Cancer, Bone Cancer, Prostate Cancer, Lung Cancer, Lymphoma, Leukaemia, Liver Cancer, Blood Cancer, Eye Cancer, Skin Cancer
- Track 5-1Medical Oncology
- Track 5-2Surgical Oncology-Surgical Techniques, General & Gynaec-onco surgeries, Radical procedures, Surgical Biopsies, Reconstructive Surgery
- Track 5-3Radiation Oncology-Radiation Therapies & Techniques, Medical Imaging, Radiobiology, Nuclear Medicine, Radiation Physics, Curative Radiation Therapy
- Track 5-4Gynaecologic Oncology
- Track 5-5Paediatric Oncology
- Track 5-6Hematologic Oncology
- Track 5-7Clinical Oncology
- Track 5-8Neuro-oncology
- Track 5-9Uro-Oncology
- Track 5-10Dermato Oncology
- Track 6-1Assessing Physical & Emotional Status
- Track 6-2Direct Patient Care
- Track 6-3Management & Palliative Care
- Track 6-4Patient Assessment & Education
- Track 6-5Supportive Care
- Track 6-6Symptom Management
- Track 6-7Treatment Plans
- Track 8-1Acupuncture
- Track 8-2Anti-Cancer Agents in Medicinal Chemistry
- Track 8-3Aromatherapy
- Track 8-4Art & Music Therapy
- Track 8-5Ayurveda
- Track 8-6Homeopathic Medicines
- Track 8-7Naturopathy
- Track 8-8Reflexology
- Track 10-1Cancer and Environment
- Track 10-2Diet and exercise
- Track 10-3Nutrition and Supplements
- Track 11-1Adoptive T-Cell transfer
- Track 11-2CAR T-Cell Therapy
- Track 11-3Clinical Trails
- Track 11-4Gene therapy
- Track 11-5HPV & Hepatitis B vaccine
- Track 11-6Oncolytic viral therapies
- Track 11-7Oncoviruses
- Track 11-8Personalised Cancer Vaccines
- Track 11-9Therapeutic Cancer Vaccines
- Track 12-1Cancer Surgery
- Track 12-2Hormonal Therapy
- Track 12-3Immunotherapy
- Track 12-4Palliative Care & Treatment
- Track 12-5Precision Medicine
- Track 12-6Radiation Therapy
- Track 12-7Stem Cell Therapy
- Track 12-8Targeted Cancer Therapies and Treatment
- Track 13-1Bone Marrow Transplantation
- Track 13-2Cancer Stem Cells
- Track 13-3CSCs and Cancer Treatment
- Track 13-4Stem Cell Transplantation
- Track 14-1Biochemical Pharmacology
- Track 14-2Cancer Drug Targets
- Track 14-3Clinical Pharmacology
- Track 14-4Clinical Toxicology
- Track 14-5Drug interactions
- Track 14-6Molecular Carcinogenesis
- Track 14-7Pharmacodynamics
- Track 14-8Pharmacokinetics
- Track 15-1Advances in Nanotechnology
- Track 15-2Cancer Microenvironment
- Track 15-3Chemo Drugs
- Track 15-4Early Diagnosis and Imaging
- Track 15-5Imaging and Theranostics
- Track 15-6New Nanomaterials
- Track 15-7Stealth Nanoparticles and Tumor Penetrating Peptides
- Track 15-8Vector/Host Interaction
- Track 17-1Antibody Therapy
- Track 17-2Cancer Antigens & Vaccines
- Track 17-3Cancer Immunosurveillance and Immunoediting
- Track 17-4Cellular Immunotherapy
- Track 17-5Clinical Cancer immunology
- Track 17-6Combination & Combinatorial Ablation and Immunotherapies
- Track 17-7Cytokine Therapy
- Track 17-8Host-Tumour Relation
- Track 18-1Cancer Etiology
- Track 18-2Cancer Risk Prediction
- Track 18-3Environmental Carcinogens
- Track 18-4Gene-Environment Interactions
- Track 18-5Genetic and molecular epidemiology
- Track 18-6Health Disparities
- Track 19-1Adverse effects
- Track 19-2Cancer Therapeutics, Novel and experimental approaches
- Track 19-3Limitations
- Track 19-4Treatment strategies
- Track 20-1Cancer Epigenetics
- Track 20-2Oncogenes & Proto-oncogenes
- Track 20-3Tumor Biology
- Track 20-4Tumour Suppressor Genes
- Track 21-1Diagnostic Biomarkers
- Track 21-2Tumour Suppressors Biomarkers
- Track 21-3Predictive & Prognostic Biomarkers
- Track 21-4Companion Biomarker
- Track 21-5Biomarkers in Cancer Research
- Track 21-6Biomarkers in Medicine
- Track 21-7Biomarkers in Cancer Medicine
- Track 21-8Risk assessment, Diagnosis
- Track 21-9Prognosis, Screening and treatment predictions
- Track 21-10Pharmacodynamics and pharmacokinetics
- Track 21-11Molecular cancer biomarkers